References
1 World Health Organization/Diabetes
2 National Diabetes Statistics Report 2022
3 American Diabetes Association, Economic Costs of Diabetes in the US in 2017. Diabetes Care 2018;41(5): 917 – 928
4 Saydah SH. Medication Use and Self-Care Practices in Persons With Diabetes. In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 39.
5 Duca FA, Waise TMZ, Peppler WT, Lam TKT. The Metabolic Impact of Small Intestinal Nutrient Sensing. Nature Communications. 2021;12(1):903.
6Blouet C, Schwartz GJ. Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats. PLOS ONE. 2012;7(12):e51898.
7Verdam FJ, Greve JWM, Roosta S, et al. Small Intestinal Alterations in Severely Obese Hyperglycemic Subjects. J Clin Endocrinol Metab. 2011;96(February):379-383. doi:10.1210/jc.2010-1333
8 Theodorakis MJ, Carlson O, Michopoulos S, et al. Human duodenal enteroendocrine cells : source of both incretin peptides , GLP-1 and GIP. Am J Physiol Endocrinol Metab. 2006;290:E550-E559. doi:10.1152/ajpendo.00326.2004.
9 Metabolic Syndrome and Related Disorders. 2017 Volume 15, Number 6, Pp. 259–262 DOI: 10.1089/met.2017.0015
10Fang M, Wang D, Coresh J, Selvin E. Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018. N Engl J Med 2021; 384:2219-28.
DOI: 10.1056/NEJMsa2032271